• Login
  • Register
Nairametrics
  • Home
  • Exclusives
    • Financial Analysis
    • Corporate Stories
    • Interviews
    • Investigations
    • Metrics
    • Economy
    • Nairalytics
  • Markets
    • Currencies
    • Cryptos
    • Commodities
    • Equities
      • Company Results
      • Dividends
      • Stock Market
    • Fixed Income
    • Market Views
    • Securities
  • Sectors
    • Agriculture
    • Aviation
    • Company News
    • Consumer Goods
    • Corporate Updates
    • Corporate deals
    • Corporate Press Releases
    • Energy
    • Entertainment
    • Financial Services
    • Health
    • Hospitality & Travel
    • Manufacturing
    • Real Estate and Construction
    • Renewables & Sustainability
    • Tech News
  • Business News
    • Budget
    • Public Debt
    • Funds Management
    • Tax
  • Financial Literacy
    • Career tips
    • Personal Finance
  • Lifestyle
    • Billionaire Watch
    • Profiles
  • Opinions
    • Blurb
    • Op-Eds
    • Research Analysis
  • Recapitalization
    • Access Holdings Offer
    • Fidelity Bank Offer
    • GTCO Offer
    • Zenith Bank Offer
  • Home
  • Exclusives
    • Financial Analysis
    • Corporate Stories
    • Interviews
    • Investigations
    • Metrics
    • Economy
    • Nairalytics
  • Markets
    • Currencies
    • Cryptos
    • Commodities
    • Equities
      • Company Results
      • Dividends
      • Stock Market
    • Fixed Income
    • Market Views
    • Securities
  • Sectors
    • Agriculture
    • Aviation
    • Company News
    • Consumer Goods
    • Corporate Updates
    • Corporate deals
    • Corporate Press Releases
    • Energy
    • Entertainment
    • Financial Services
    • Health
    • Hospitality & Travel
    • Manufacturing
    • Real Estate and Construction
    • Renewables & Sustainability
    • Tech News
  • Business News
    • Budget
    • Public Debt
    • Funds Management
    • Tax
  • Financial Literacy
    • Career tips
    • Personal Finance
  • Lifestyle
    • Billionaire Watch
    • Profiles
  • Opinions
    • Blurb
    • Op-Eds
    • Research Analysis
  • Recapitalization
    • Access Holdings Offer
    • Fidelity Bank Offer
    • GTCO Offer
    • Zenith Bank Offer
Nairametrics
No Result
View All Result
Home Spotlight

Pfizer and BioNTech vaccines gets full approval from the FDA

Chidinma Anyalewechi by Chidinma Anyalewechi
August 23, 2021
in Spotlight
Pfizer and BioNTech Vaccines Gets Full Approval From the FDA
Share on FacebookShare on TwitterShare on Linkedin

The Covid-19 vaccine made by Pfizer Inc. and BioNTech SE has been granted full approval by U.S. regulators. It is believed that this move is a milestone expected to help bolster and encourage the immunization drive as the country records a surge in infections fueled by the delta variant.

In a statement by the Food and Drug Administration, the Federal agency said that it had cleared the shot for the prevention of the disease caused by the novel coronavirus in people 16 years old and older and it will be marketed under the Comirnaty.

FDA-approved vaccines undergo the agency’s standard process for reviewing the quality, safety and effectiveness of medical products. For all vaccines, the FDA evaluates data and information included in the manufacturer’s submission of a biologics license application (BLA).

RelatedStories

U.S court renews suit against AstraZeneca Plc, Pfizer Inc, others

U.S court renews suit against AstraZeneca Plc, Pfizer Inc, others

January 5, 2022
OFFICIAL: UK Approves Covid-19 Vaccine made by Pfizer/BioNTech

Pfizer requests FDA authorization for Covid booster shots for adults

November 10, 2021

The approval is the first for a Covid vaccine, and it arrives at a crucial time in the trajectory of the pandemic, as the U.S. is ensnared in a wave of illness sparked by the highly transmissible delta mutation. The Biden administration has made increasing vaccinations a priority in its efforts to tamp down the latest outbreak.

The two-dose regimen was initially made available in the U.S. through an emergency authorization late last year. It has since become the most widely used of three available vaccines, according to data from the Centers for Disease Control and Prevention, with more than 92 million people have received two shots.

The vaccine continues to be available to people age 12 to 15 under an emergency use authorization, the FDA said.

The approval is expected to boost confidence in the shot among people who say they are wary of its rapid-fire development and could open the door to more vaccination requirements among employers and businesses.

It is also likely to solidify the shot’s status as a blockbuster for its makers. Pfizer said last month it expects the vaccine to bring in $33.5 billion in revenue this year, a total that would place it among the biggest-selling drugs of all time. In the second quarter, the vaccine booked $7.8 billion in sales.

Pfizer shares rose 3.7% at 10:14 a.m. in New York trading today, Monday, August 23rd, 2021, while BioNTech shares jumped 8.8%. Pfizer expects to file a BLA for its vaccine in those aged 12-to-15 before the end of the year. For those under 12, the process will take even longer.

Other vaccines could receive approvals in the coming months. In June, Moderna Inc. said it had initiated a rolling submission of its Biologics License Application for its vaccine in people 18 and older. Neither Moderna Inc. nor Johnson & Johnson have yet approached U.S. regulators with a Biologics License Application for any age group.


Follow us for Breaking News and Market Intelligence.
Tags: BioNTech SEFood and Drug AdministrationPfizer Inc.
Chidinma Anyalewechi

Chidinma Anyalewechi

For further inquiries about this article, contact: Email: chidinma.anyalewechi@nairametrics.com LinkedIn: linkedin.com/in/chidinma-anyalewechi-a323ab173/

Related Posts

U.S court renews suit against AstraZeneca Plc, Pfizer Inc, others
Legal & Regulations

U.S court renews suit against AstraZeneca Plc, Pfizer Inc, others

January 5, 2022
OFFICIAL: UK Approves Covid-19 Vaccine made by Pfizer/BioNTech
Socio Economic

Pfizer requests FDA authorization for Covid booster shots for adults

November 10, 2021
Moderna says its Covid vaccine generates strong immune response in 6-11 year-olds
Socio Economic

Moderna says its Covid vaccine generates strong immune response in 6-11 year-olds

October 26, 2021
Pfizer asks United States to allow administration of Covid shots for kids aged 5-to-11
Socio Economic

Pfizer asks United States to allow administration of Covid shots for kids aged 5-to-11

October 8, 2021
Johnson & Johnson to request FDA authorization for vaccine booster shots
Socio Economic

Johnson & Johnson to request FDA authorization for vaccine booster shots

October 4, 2021
International Organizations, Vaccine manufacturers strategize to achieve vaccination threshold
Socio Economic

FDA authorizes Pfizer’s Covid booster shots for Americans deemed “most at risk”

September 23, 2021
Next Post
Nigerian-born Giannis Antetokounmpo joins ownership group of Milwaukee Brewers

Nigerian-born Giannis Antetokounmpo joins ownership group of Milwaukee Brewers

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

first bank








DUNS

Recent News

  • Gamsole founder Abiola Olaniran, 36, dies 
  • FG, Femi Otedola deny involvement in FirstHoldCo’s N323 billion share acquisition 
  • Appeal Court prohibits Human Rights Commission from entertaining Oil Spillage Complaints in Nigeria 

Follow us on social media:

Recent News

Gamsole founder Abiola Olaniran, 36, dies 

Gamsole founder Abiola Olaniran, 36, dies 

July 18, 2025
Buy, Sell or Hold – FirstHoldco?

FG, Femi Otedola deny involvement in FirstHoldCo’s N323 billion share acquisition 

July 18, 2025
  • iOS App
  • Android App
  • Contact Us
  • Home
  • Markets
  • Sectors
  • Economy
  • Business News
  • Financial Literacy
  • Disclaimer
  • Ads Disclaimer
  • Copyright Infringement

© 2025 Nairametrics

Welcome Back!

Login to your account below

Forgotten Password? Sign Up

Create New Account!

Fill the forms below to register

All fields are required. Log In

Retrieve your password

Please enter your username or email address to reset your password.

Log In
Social Media Auto Publish Powered By : XYZScripts.com
No Result
View All Result
  • Home
  • Exclusives
    • Financial Analysis
    • Corporate Stories
    • Interviews
    • Investigations
    • Metrics
    • Economy
    • Nairalytics
  • Markets
    • Currencies
    • Cryptos
    • Commodities
    • Equities
      • Company Results
      • Dividends
      • Stock Market
    • Fixed Income
    • Market Views
    • Securities
  • Sectors
    • Agriculture
    • Aviation
    • Company News
    • Consumer Goods
    • Corporate Updates
    • Corporate deals
    • Corporate Press Releases
    • Energy
    • Entertainment
    • Financial Services
    • Health
    • Hospitality & Travel
    • Manufacturing
    • Real Estate and Construction
    • Renewables & Sustainability
    • Tech News
  • Business News
    • Budget
    • Public Debt
    • Funds Management
    • Tax
  • Financial Literacy
    • Career tips
    • Personal Finance
  • Lifestyle
    • Billionaire Watch
    • Profiles
  • Opinions
    • Blurb
    • Op-Eds
    • Research Analysis
  • Recapitalization
    • Access Holdings Offer
    • Fidelity Bank Offer
    • GTCO Offer
    • Zenith Bank Offer
  • Login
  • Sign Up

© 2025 Nairametrics